Literature DB >> 24923363

Hepatocellular carcinoma based on cryptogenic liver disease: The most common non-viral hepatocellular carcinoma in patients aged over 80 years.

Katsutoshi Tokushige1, Etsuko Hashimoto, Yoshinori Horie, Makiko Taniai, Susumu Higuchi.   

Abstract

AIM: To clarify the clinical features of patients with hepatocellular carcinoma (HCC) with cryptogenic liver diseases, we analyzed the data from a nationwide survey in Japan.
METHODS: The survey was conducted in 2009. The factors examined included age and underlying liver diseases: alcoholic liver disease (ALD; n = 991), non-alcoholic fatty liver disease (n = 292), modest alcohol intake (intake between 20 and 70 g/day, n = 214) and cryptogenic liver diseases (n = 316). We compared the clinical features of cryptogenic HCC among patient-age subgroups.
RESULTS: HCC with ALD etiology was most common among the non-viral HCC patients under 80 years old; for those aged 80 years or older, cryptogenic HCC was the most common etiology. Among the cryptogenic HCC patients, the body mass index values and the prevalences of liver cirrhosis (LC) and diabetes mellitus (DM) were significantly lower in the 80 years or older group versus the 50-79 years group. In the 80 years or older group, 28% of the patients developed HCC without cirrhosis, obesity and DM.
CONCLUSION: In the HCC patients aged 80 years and over, the etiology of most of the non-viral HCC cases was classified as cryptogenic. In light of our finding that the prevalences of obesity, DM and LC in the 80 years or older group of cryptogenic HCC patients were significantly lower those in the younger patients, it is apparent that analyses of HCC cases must take age differences into account.
© 2014 The Japan Society of Hepatology.

Entities:  

Keywords:  cryptogenic liver disease; diabetes mellitus; hepatocellular carcinoma; liver cirrhosis; old age

Year:  2014        PMID: 24923363     DOI: 10.1111/hepr.12372

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  6 in total

1.  The Importance of Metabolic Syndrome Status for the Risk of Non-Viral Hepatocellular Carcinoma: A Nationwide Population-Based Study.

Authors:  Yuri Cho; Eun Ju Cho; Jeong-Ju Yoo; Young Chang; Goh Eun Chung; In Young Choi; Sang-Hyun Park; Kyungdo Han; Yoon Jun Kim; Jung-Hwan Yoon; Dong Wook Shin; Su Jong Yu
Journal:  Front Oncol       Date:  2022-05-04       Impact factor: 5.738

2.  Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter survey.

Authors:  Katsutoshi Tokushige; Hideyuki Hyogo; Tomoaki Nakajima; Masafumi Ono; Takumi Kawaguchi; Koichi Honda; Yuichiro Eguchi; Yuichi Nozaki; Miwa Kawanaka; Saiyu Tanaka; Kento Imajo; Yoshio Sumida; Yoshihiro Kamada; Hideki Fujii; Yasuaki Suzuki; Tomomi Kogiso; Yoshiyasu Karino; Kensuke Munekage; Ryoko Kuromatsu; Satoshi Oeda; Mikio Yanase; Kohjiro Mori; Yuji Ogawa; Yuya Seko; Tetsuo Takehara; Yoshito Itoh; Atsushi Nakajima; Kazuyuki Kanemasa; Ken Nishino; Naohiko Masaki; Hirokazu Takahashi; Masataka Seike; Takuji Torimura; Toshiji Saibara; Joji Toyota; Kazuaki Chayama; Etsuko Hashimoto
Journal:  J Gastroenterol       Date:  2015-10-11       Impact factor: 7.527

3.  Long-term prognosis after resection of cryptogenic hepatocellular carcinoma.

Authors:  Yu Ohkura; Kazunari Sasaki; Masamichi Matsuda; Masaji Hashimoto; Goro Watanabe
Journal:  BMC Surg       Date:  2015-10-17       Impact factor: 2.102

4.  Prognoses, outcomes, and clinicopathological characteristics of very elderly patients with hepatocellular carcinoma who underwent hepatectomy.

Authors:  Shingo Shimada; Toshiya Kamiyama; Tatsuya Orimo; Akihisa Nagatsu; Yoh Asahi; Yuzuru Sakamoto; Hirofumi Kamachi; Akinobu Taketomi
Journal:  World J Surg Oncol       Date:  2020-06-10       Impact factor: 2.754

Review 5.  Utilization of animal models to investigate nonalcoholic steatohepatitis-associated hepatocellular carcinoma.

Authors:  Jian Wu
Journal:  Oncotarget       Date:  2016-07-05

Review 6.  Characteristic Features of Nonalcoholic Fatty Liver Disease in Japan with a Focus on the Roles of Age, Sex and Body Mass Index.

Authors:  Maki Tobari; Etsuko Hashimoto
Journal:  Gut Liver       Date:  2020-09-15       Impact factor: 4.519

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.